Target intelligence / Profile preview

Eukaryotic translation elongation factor 1 alpha 1 pseudogene 39 (EEF1A1P39)

Target
EEF1A1P39
Molecular classification
Other, pseudogene
01

Overview

Eukaryotic translation elongation factor 1 alpha 1 pseudogene 39 (EEF1A1P39) is classified as a pseudogene, meaning it is a non-functional genomic sequence related to the protein-coding gene EEF1A1, which encodes a component of the translation elongation complex involved in protein synthesis. Pseudogenes like EEF1A1P39 are generally considered non-coding and do not produce functional proteins. There is no evidence in current databases that EEF1A1P39 acts as a therapeutic target, possesses well-characterized biological functions, or is implicated as a biomarker or drug target. Most EEF1A1 pseudogenes, including EEF1A1P39, are not well characterized, and there is no evidence that EEF1A1P39 is relevant to disease mechanisms or drug response at present. EEF1A1P39 is a pseudogene, not an active receptor, enzyme, transporter, or transcription factor. The parental gene, EEF1A1, encodes elongation factor 1-alpha 1, a well-studied protein essential for translation; however, pseudogenes derived from EEF1A1 (such as EEF1A1P39) are typically non-functional remnants with no known protein product or therapeutic relevance. Some EEF1A1 pseudogenes have been tentatively linked to disease studies via association or expression-level changes, but there is no evidence for functional or druggable activity in EEF1A1P39 specifically. EEF1A1P39 has not been identified as a target for any approved or experimental drug, nor has it been identified as a clinical biomarker, disease gene, or therapeutic safety concern. EEF1A1P39 is a pseudogene with no evidence supporting its role as a therapeutic target, disease gene, or biomarker. Its listing as a "target" is incorrect; it is best classified as non-functional genomic DNA related to the EEF1A1 gene.

Other names
EEF1A1P39

Beyond the preview

Go deeper on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 39 (EEF1A1P39).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 39 (EEF1A1P39).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call